A swift clinical translation of our discovery is supported by the availability of α-IL13 monoclonal antibodies that are currently optimized for the treatment of severe asthma71 and the prospect of developing companion diagnostics for early detection of GC and patient stratification. The gene discussed is IL13; the disease is gastric cancer.